Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postmarketing surveillance methodologies.

S A Edlavitch1

  • 1University of Minnesota, Minneapolis 55455.

Drug Intelligence & Clinical Pharmacy
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consanguinity, prematurity, birth weight and pregnancy loss: a prospective cohort study at four primary health center areas of Karnataka, India.

Journal of perinatology : official journal of the California Perinatal Association·2011
Same author

Drape estimation vs. visual assessment for estimating postpartum hemorrhage.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2006
Same author

Conducting international collaborative research in developing nations.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2004
Same author

Antipolymer antibodies, silicone breast implants, and fibromyalgia.

Lancet (London, England)·1997
Same author

Secular trends in Q wave and non-Q wave acute myocardial infarction. The Minnesota Heart Survey.

Circulation·1991
Same author

[Brief introduction to pharmacoepidemiology].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·1990
Same journal

Profile of prescription medication in a pediatric population.

Drug intelligence & clinical pharmacy·1988
Same journal

SI units in drug therapeutics.

Drug intelligence & clinical pharmacy·1988
Same journal

Physicians' review of significant interventions by clinical pharmacists in inpatient care.

Drug intelligence & clinical pharmacy·1988
Same journal

Possible interaction of ranitidine with phenytoin.

Drug intelligence & clinical pharmacy·1988
Same journal

Famotidine-associated mental confusion in elderly patients.

Drug intelligence & clinical pharmacy·1988
Same journal

Intravenous self-administration of elemental mercury: efficacy of dimercaprol therapy.

Drug intelligence & clinical pharmacy·1988
See all related articles

This review covers pharmacoepidemiologic methods for postmarketing drug surveillance, detailing strengths and weaknesses of various study designs. It highlights the U.S. system

Area of Science:

  • Pharmacoepidemiology
  • Drug Safety
  • Public Health

Background:

  • Postmarketing drug surveillance is crucial for evaluating medication efficacy and safety after market approval.
  • Understanding the strengths and limitations of various methodologies is essential for robust drug safety assessments.

Purpose of the Study:

  • To describe and discuss the major pharmacoepidemiologic methodologies used in postmarketing drug surveillance.
  • To outline the current status of the U.S. drug surveillance system.
  • To provide examples of pharmacoepidemiologic studies utilizing different methodologies.

Main Methods:

  • Controlled clinical trials
  • Observational epidemiologic studies (cohort, case-control, cross-sectional)
  • Demographic methods, drug utilization surveys, spontaneous reports, and automated databases

Related Experiment Videos

Main Results:

  • Each methodology possesses unique strengths and limitations for drug safety evaluation.
  • A combination of methodologies is typically employed to address efficacy and safety questions.
  • The U.S. surveillance system integrates multiple data sources for comprehensive drug monitoring.

Conclusions:

  • Effective postmarketing drug surveillance relies on a diverse set of pharmacoepidemiologic tools.
  • Collaboration between regulatory agencies, pharmaceutical manufacturers, and academic institutions is vital.
  • Continued evaluation and refinement of surveillance methods ensure public health protection.